Association of H-ras polymorphisms and susceptibility to sporadic colon cancer

International Journal of Oncology

Volumn 35, Issue 5, 2009, Pages 1169-1173

  Ivkovic, Tina Catela ^a   Loncar, Bozo ^b   Spaventi, Radan ^c   Kapitanovic, Sanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

H ras; Hexanucleotide repeats; Polymorphism; SNP 81T>C; Sporadic colon cancer

Indexed keywords

RAS PROTEIN;

AGED; ARTICLE; COLON CANCER; CONTROLLED STUDY; CROATIA; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

COLONIC NEOPLASMS; CROATIA; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 70449572889     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000433     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988. (Pubitemid 18121766)
3. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989. (Pubitemid 19213607)
4. Krontiris TG: Oncogenes. N Engl J Med 333: 303-306, 1995.
5. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours. Int J Oncol 7: 413-429, 1995.
6. Malumbres M and Barbacid M: RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459-465, 2003.
7. Leon J, Guerrero I and Pellicer A: Differential expression of the ras gene family in mice. Mol Cell Biol 7: 1535-1540, 1987. (Pubitemid 17045244)
8. Junien C and McBride OW: Report of the committee on the genetic constitution of chromosome 11. Cytogenet Cell Genet 51: 226-258, 1989.
9. Bos JL, Verlaan-de Vries M, Marshall CJ, Veeneman GH, van Boom JH and van der Eb AJ: A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res 14: 1209-1217, 1986. (Pubitemid 16141570)
10. Hashimoto-Gotoh T, Kikuno R, Takahashi M and Honkawa H: Possible role of the first intron of c-H-ras in gene expression: anti-cancer elements in oncogenes. Anticancer Res 8: 851-859, 1988. (Pubitemid 18232015)
11. Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M and Wigler M: Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300: 762-765, 1982. (Pubitemid 13224357)
12. Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H and Wolf P: High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 74: 323-330, 2001.
13. Johne A, Roots I and Brockmoller J: A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer. Cancer Epidemiol Biomarkers Prev 12: 68-70, 2003. (Pubitemid 36110161)
14. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkström H, Larsson P, Kumar R and Hemminki K: Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25: 729-734, 2004. (Pubitemid 38618524)
15. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42: 607-613, 2006. (Pubitemid 43947667)
16. Zhang Y, Jin M, Liu B, Ma X, Yao K, Li Q and Chen K: Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China. BMC Cancer 8: 256, 2008.
17. Sol-Church K, Stabley DL, Nicholson L, Gonzalez IL and Gripp KW: Paternal bias in parental origin of HRAS mutations in Costello syndrome. Hum Mutat 27: 736-741, 2006. (Pubitemid 44205066)
18. Iwahana H, Orita M and Kanazawa H: A new RFLP in intron 1 of the human c-Ha-ras1 gene and its close relationship with the variable tandem repeats in the region 3′ to the gene. Oncogene 5: 1049-1053, 1990. (Pubitemid 20220248)
19. Tanci P, Genuardi M, Santini SA and Neri G: PCR detection of an insertion/deletion polymorphism in intron 1 of the HRAS1 locus. Nucleic Acids Res 20: 1157, 1992.
20. Spaventi R, Pecur L, Pavelic K, Pavelic ZP, Spaventi S and Stambrook PJ: Human Tumor Bank in Croatia: a possible model for a small bank as a part of future European tumor bank network. Eur J Cancer 30A: 419, 1994. (Pubitemid 24152494)
21. Kotsinas A, Vageli D, Varakliotou A, Anezinis P, Cranidis A and Spandidos DA: Genomic instability and LOH at two polymorphic sites in the H-ras1 gene. Int J Oncol 5: 1249-1253, 1994. (Pubitemid 24357466)
22. Kotsinas A, Gorgoulis VG, Zacharatos P, Mariatos G, Kokotas S, Liloglou T, Ikonomopoulos J, Zoumpourlis V, Kyroudi A, Field JK, Asimacopoulos PJ and Kittas C: Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. Cancer Genet Cytogenet 126: 147-154, 2001. (Pubitemid 32453332)
23. Papadakis EN, Dokianakis DN and Spandidos DA: Genetic analysis of H-ras intron-1 polymorphic and variable tandem repeat regions in human breast cancer. Int J Biol Markers 18: 195-199, 2003.
24. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TWJ and Harris PE: Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol 50: 529-535, 1999. (Pubitemid 29193238)
25. Capon DJ, Chen EY, Levinson AD, Seeburg PH and Goeddel DV: Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302: 33-37, 1983.
26. Castro P, Soares P, Gusmão L, Seruca R and Sobrinho-Simões M: H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid. Oncogene 25: 4620-4627, 2006. (Pubitemid 44175121)
27. Spandidos DA and Wilkie NM: The normal human H-ras1 gene can act as an oncosuppressor. Br J Cancer 58: 67-71, 1988.
28. Spandidos DA, Frame M and Wilkie NM: Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes. Anticancer Res 10: 1543-1554, 1990.
29. Spandidos DA, Sourvinos G, Tsatsanis C and Zafiropoulos A: Normal ras genes: their onco-suppressor and pro-apoptotic functions (Review). Int J Oncol 21: 237-241, 2002.